Taizhou, Jiangsu, China Related Funds
| Fund Name | Location |
| Avva Technology Pte Ltd | Central, Central Region, Singapore |
| Beijing Envision Investment Management Co. | Beijing, Beijing, China |
| Corp Strategics | - |
| Crescendix | France, Ile-de-France, Paris |
| Dolphin Equity Partners | New York, New York, United States |
| Equinix Japan | Japan, Tokyo |
| Gordon Food Service | Grand Rapids, Michigan, United States |
| Gradiente Sgr | Italy, Padua, Veneto |
| Greenlight Reinsurance | Cayman Islands, Midland |
| Huckletree Alpha Programme London | England, London, United Kingdom |
| Huochebang | China, Guizhou, Liaoning |
| Lucas Point Ventures | New York, New York, United States |
| Power Law Capital | - |
| Scripps Networks | Knoxville, Tennessee, United States |
| Shanghai Xiangyi Touzi Guanli Youxian Gongsi | China, Shanghai |
| Sherbrooke Innopole | Canada, Quebec, Sherbrooke |
| Sport & Performance Capital | - |
| Tap4Fun | Chengdu, China, Sichuan |
| Torteval Investments | England, London, United Kingdom |
| Wren House Infrastructure | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
IMPACT Therapeutics | $50M | 01 Dec 2020 | Xuanwu District, Jiangsu, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
IMPACT Therapeutics | $50M | 01 Dec 2020 | Xuanwu District, Jiangsu, China |
